Research study Program year 2022 Source: CMS Open Payments

A Phase I/II, Randomized, Placebo-Controlled, Observer-Blind, Multicen

Research payments

$805,322

311 payments

Through program year 2022, $805,322 in research payments was reported against A Phase I/II, Randomized, Placebo-Controlled, Observer-Blind, Multicen, across 311 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2022	Research	$1,175	1
2021	Research	$500	1
2020	Research	$803,647	309

Breakdown

Who paid Research payments · program years 2020–2022

GlaxoSmithKline, LLC. $805,322 311 payments

Who received the money Research payments · program years 2020–2022

Rochester Clinical Research Organisation paid for research $196,862 43 payments
Alliance For Multispecialty Researc Organisation paid for research $107,278 63 payments
Johnson County Clinic Trials Organisation paid for research $96,840 25 payments
Pmg Research INC Organisation paid for research $85,066 45 payments
Meridian Clinical Research LLC Organisation paid for research $70,231 10 payments
Texas Center For Drug Development Organisation paid for research $40,551 15 payments
Jacksonville Center For Clinical Organisation paid for research $35,681 16 payments
Crisor LLC Organisation paid for research $28,825 13 payments
Lung Diagnostics Ltd Organisation paid for research $26,974 16 payments
Georgia Allergy & Respiratory Ins Organisation paid for research $26,007 7 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.